OpenEvidence has reached $12 billion, with a new round led by Thrive, DST

The venture capitalists who backed OpenEvidence don’t seem to be worried about that OpenAI and Anthropy New health information products.

On Wednesday, startup Announce It has raised an additional $250 million in Series D funding at a $12 billion valuation, co-led by Thrive Capital and DST.

That’s double the valuation from the last raise in October: $200 million $6 billion, led by GV. The company says it has now raised a total of $700 million from backers including Sequoia, Nvidia, Kleiner Perkins, Blackstone, Bond, Kraft Ventures, Mayo Clinic and others.

OpenEvidence is an AI-powered medical information platform, similar to the WebMD platform of the previous Internet generation, but geared toward physicians. This puts it in somewhat greater competition with Claude Anthropy Healthcarewhich is intended for patients, payers and providers, while New health product ChatGPT It targets consumers more.

The company says the free, ad-supported platform provided 18 million clinical consultations from certified healthcare professionals in the United States in December alone. This compares to about 3 million searches per month a year ago. It also said its revenue exceeded $100 million.